Psychemedics Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.4500
- Today's High:
- $6.4500
- Open Price:
- $6.4500
- 52W Low:
- $5.88
- 52W High:
- $8.65
- Prev. Close:
- $6.5550
- Volume:
- 366
Company Statistics
- Market Cap.:
- $0.036 billion
- Book Value:
- 2.122
- Revenue TTM:
- $0.026 billion
- Operating Margin TTM:
- -1.79%
- Gross Profit TTM:
- $0.010 billion
- Gross Profit TTM:
- $0.010 billion
- Profit Margin:
- -4.52%
- Return on Assets TTM:
- -1.3%
- Return on Equity TTM:
- -9.43%
Company Profile
Psychemedics Corporation had its IPO on 1994-02-17 under the ticker symbol PMD.
The company operates in the LIFE SCIENCES sector and SERVICES-MEDICAL LABORATORIES industry. Psychemedics Corporation has a staff strength of 0 employees.
Stock update
Shares of Psychemedics Corporation opened at $6.45 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $6.45 - $6.45, and closed at $6.45.
This is a -1.6% slip from the previous day's closing price.
A total volume of 366 shares were traded at the close of the day’s session.
In the last one week, shares of Psychemedics Corporation have increased by +7.5%.
Psychemedics Corporation's Key Ratios
Psychemedics Corporation has a market cap of $0.036 billion, indicating a price to book ratio of 3.031 and a price to sales ratio of 1.389.
In the last 12-months Psychemedics Corporation’s revenue was $0.026 billion with a gross profit of $0.010 billion and an EBITDA of $0.002 billion. The EBITDA ratio measures Psychemedics Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Psychemedics Corporation’s operating margin was -1.79% while its return on assets stood at -1.3% with a return of equity of -9.43%.
In Q2, Psychemedics Corporation’s quarterly earnings growth was a negative -30.2% while revenue growth was a positive 7%.
Psychemedics Corporation’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.127 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Psychemedics Corporation’s profitability.
Psychemedics Corporation stock is trading at a EV to sales ratio of 1.482 and a EV to EBITDA ratio of 12.39. Its price to sales ratio in the trailing 12-months stood at 1.389.
Psychemedics Corporation stock pays annual dividends of $0.19 per share, indicating a yield of 4.33% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Psychemedics Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Psychemedics Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Psychemedics Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Psychemedics Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Psychemedics Corporation paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $6.45
- 52-Week High
- $8.65
- 52-Week Low
- $5.88
- Analyst Target Price
- $32
Psychemedics Corporation stock is currently trading at $6.45 per share. It touched a 52-week high of $8.65 and a 52-week low of $8.65. Analysts tracking the stock have a 12-month average target price of $32.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Psychemedics Corporation
Similar Industry Stocks (SERVICES-MEDICAL LABORATORIES)
Most Active
Top Gainers
Top Losers
About
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil and internationally. The company is headquartered in Acton, Massachusetts.